Jon Cuthbert

MC Mining (ASX:MCM) reduced its net loss after tax by 51% to US$17.8 million for the financial year ended June 30.

Jade Biosciences (NASDAQ:JBIO) reported preclinical results for JADE301, an investigational antibody targeting dermatomyositis, at the European Academy of Dermatology and Venereology Congress in Vienna.

RedCloud (NASDAQ:RCT) reported revenue of $24 million for the six months ended June 30, 2026, an increase of 34% year over year, as total trading volume increased to $1.56 billion.

Novo Nordisk (NYSE:NVO) presented new CagriSema clinical data at EASD 2026, including studies evaluating food-related brain responses, organ fat changes and weight reduction in adults with overweight or obesity.

Jabil (NYSE:JBL) reported preliminary unaudited fiscal fourth-quarter 2026 revenue of $10.6 billion, with U.S. GAAP operating income of $602 million and diluted earnings per share of $3.76.

Capital Bancorp (NASDAQ:CBNK) agreed to merge into Peoples Bancorp (NASDAQ:PEBO) in an all-stock transaction valued at approximately $728.1 million, creating a combined banking franchise with expanded commercial and specialty lending operations.

Concentrix Corporation (NASDAQ:CNXC) shares declined 11.5% premarket to $22.02 after the technology and services company reported a third-quarter 2026 loss following a $1.05 billion non-cash goodwill impairment charge.

AbbVie (NYSE:ABBV) announced that it will present 60 dermatology research abstracts, including three late-breaking presentations, at the 2026 European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria, covering multiple immune-mediated skin diseases.

New South Wales Senator David Shoebridge has been elected as the new leader of the Australian Greens.

Lindian Resources (ASX:LIN) has confirmed its Kangankunde concentrate exports remain unaffected by Malawi's 2025 executive order.